The impact of HMG-CoA reductase inhibition on the incidence and severity of graft-versus-host disease in patients with acute leukemia undergoing allogeneic transplantation. Blood 2008 Apr 01;111(7):3901-2
Date
03/26/2008Pubmed ID
18362217DOI
10.1182/blood-2008-01-132050Scopus ID
2-s2.0-43549086236 (requires institutional sign-in at Scopus site) 41 CitationsAuthor List
Hamadani M, Awan FT, Devine SMAuthor
Mehdi H. Hamadani MD Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Acute DiseaseAdult
Aged
Disease-Free Survival
Female
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Leukemia
Male
Middle Aged
Retrospective Studies
Survival Rate
Transplantation, Homologous
